The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 281.00
Bid: 282.50
Ask: 285.00
Change: -6.00 (-2.09%)
Spread: 2.50 (0.885%)
Open: 280.00
High: 287.50
Low: 280.00
Prev. Close: 287.00
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

22 Oct 2019 07:00

RNS Number : 5705Q
Synthomer PLC
22 October 2019
 

 

 

 

LEI Number: 213800EHT3TI1KPQQJ56

 

Synthomer plc ("the Company") - 2019 AGM voting outcome update statement

 

 

 

In its 2019 AGM results announcement, the Company reported that all resolutions were passed, although there was a significant minority vote against resolution 11 which related to the re-election of Neil Johnson, the Chairman of the Company, as a non-executive director. Total votes received in favour of this resolution were 64.72%.

 

Following the AGM results, the Company has actively sought to engage in dialogue with a number of significant shareholders who voted against Neil's re-election and with a leading proxy voting advisory body. The dialogue was initiated in order to better understand the reasons behind the dissenting votes, which were based on:

 

·; Concerns over Neil's availability to devote sufficient time to carry out his responsibilities as Chairman of the Company ("over boarding"); and

 

·; The absence of a commitment and plan by the Synthomer Board ("the Board") to implement the Hampton-Alexander Review Recommendation of 33% representation of women on the Board by the end of 2020) ("the Recommendation").

 

 

The Board has carefully considered the over boarding' concerns which are understood to arise due to Neil's role as chair of two other public company boards - QinetiQ Group plc (QinetiQ) and Electra Private Equity plc (Electra). Whilst the Board acknowledges that Neil's role as chairman of the QinetiQ board is a significant commitment which should be counted as such this is not however considered to be the case with his chairmanship of Electra. As Electra has publicly stated, it is conducting a managed wind-down of its final few investments and reducing overheads prior to closing the fund which has currently resulted in it having only two employees and requiring minimal input from Neil. Accordingly, the Board strongly believes that Neil is an effective Chairman with sufficient capacity to meet his commitments, and has no concerns over his availability to deal with Company matters.

 

The Board adopted its current policy on diversity in 2014 and has not recommended the setting of quotas for female or other representation. The Board has appointed women to fill the most recent two vacancies that have arisen for independent non-executive directors resulting in female representation of 22.2% on the Board since September 2018. In order to address both the Recommendation and the need for the refreshment of independent non-executive directors over the next 18 months in accordance with the provisions of the UK Corporate Governance Code ("the Code") the Board has decided to commit to the appointment of an additional female independent non-executive director by the end of 2020. Whilst this will increase the size of the Board in the short term to 10 it is expected that the Board will reduce to 9 during the first half of 2021. It should be noted that the Board has two long standing male non independent non-executive directors who are not subject to the tenure requirements of the Code and who each continue to provide a highly valued contribution.

 

The Board will continue to engage with shareholders on these points as required and will set out further details of any such dialogue and relevant justification for the re-election for all members of the Board in the 2020 annual report and accounts and associated documentation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMBGBDGBSDBGCB
Date   Source Headline
9th May 20242:29 pmRNSResults of AGM
9th May 20247:00 amRNSTrading Statement - Spring 2024
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.